• 1
    Pegues DA, Miller SI. Salmonella species, including Salmonella Typhi. In: MandellGL, BennettJE, DolinR, eds. Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 6th edn. Philadelphia, PA: Churchill Livingstone, Elsevier, 2009;28872903.
  • 2
    Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607625.
  • 3
    Adak GK, Long SM, O’Brien SJ. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 2002; 51: 832841.
  • 4
    Voetsch AC, Van Gilder TJ, Angulo FJ et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 2004; 38 (suppl 3): S127S134.
  • 5
    Kennedy M, Villar R, Vugia DJ et al. Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996–1999. Clin Infect Dis 2004; 38 (suppl 3): S142S148.
  • 6
    Trevejo RT, Courtney JG, Starr M, Vugia DJ. Epidemiology of salmonellosis in California, 1990–1999: morbidity, mortality, and hospitalization costs. Am J Epidemiol 2003; 157: 4857.
  • 7
    Vugia DJ, Samuel M, Farley MM et al. Invasive Salmonella infections in the United States, FoodNet, 1996–1999: incidence, serotype distribution, and outcome. Clin Infect Dis 2004; 38 (suppl 3): S149S156.
  • 8
    Gradel KO, Schonheyder HC, Pedersen L, Thomsen RW, Norgaard M, Nielsen H. Incidence and prognosis of non-typhoid Salmonella bacteraemia in Denmark: a 10-year county-based follow-up study. Eur J Clin Microbiol Infect Dis 2006; 25: 151158.
  • 9
    Ternhag A, Torner A, Ekdahl K, Giesecke J. Salmonella-associated deaths, Sweden, 1997–2003. Emerg Infect Dis 2006; 12: 337339.
  • 10
    Shimoni Z, Pitlik S, Leibovici L et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999; 28: 822827.
  • 11
    Levine WC, Buehler JW, Bean NH, Tauxe RV. Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic. J Infect Dis 1991; 164: 8187.
  • 12
    Jones TF, Ingram LA, Cieslak PR et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008; 198: 109114.
  • 13
    Helms M, Simonsen J, Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 2004; 190: 16521654.
  • 14
    Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study. BMJ 2003; 326: 357360.
  • 15
    Weinberger M, Keller N. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis 2005; 18: 513521.
  • 16
    European Food Safety Authority, European Centre for Disease Prevention and Control. The Community summary report on trends and sources of zoonoses and zoonotic agents in the European Union in 2007. EFSA J 2009;223:1312.
  • 17
    Weinberger M, Solnik-Isaac H, Shachar D et al. Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel. Clin Microbiol Infect 2006; 12: 9991005.
  • 18
    Solnik-Isaac H, Weinberger M, Tabak M, Ben-David A, Shachar D, Yaron S. Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion. J Clin Microbiol 2007; 45: 25752579.
  • 19
    Bar-Meir M, Raveh D, Yinnon AM, Benenson S, Rudensky B, Schlesinger Y. Non-Typhi Salmonella gastroenteritis in children presenting to the emergency department: characteristics of patients with associated bacteraemia. Clin Microbiol Infect 2005; 11: 651655.
  • 20
    Kauffmann F. Classification of bacteria. A realistic scheme with special reference to the classification of Salmonella and Escherichia species. Copenhagen: Munksgaard, 1975.
  • 21
    Taeger D, Sun Y, Keil U, Straif K. A stand-alone windows applications for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology 2000; 11: 607608.
  • 22
    Gradel KO, Schonheyder HC, Lundbye-Christensen S, Ejlertsen T, Nielsen H. Severity of human non-typhoid salmonellosis as a predictor of short- and long-term mortality. Scand J Infect Dis 2009; 41: 99104.
  • 23
    Weinberger M, Andorn N, Agmon V, Cohen D, Shohat T, Pitlik SD. Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol Infect 2004; 132: 10231028.
  • 24
    Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of Salmonella infections. Medicine 1987; 66: 349388.
  • 25
    Treanor JJ. Influenza virus. In: MandellGL, BennettJE, DolinR, eds. Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Elsevier, Churchill Livingstone, 2005; 20602085.
  • 26
    Baker GR, Norton PG, Flintoft V et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170: 16781686.
  • 27
    Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807812.
  • 28
    Green MS, Weinberger M, Ben-Ezer J et al. Long-term death rates, West Nile virus epidemic, Israel, 2000. Emerg Infect Dis 2005; 11: 17541757.
  • 29
    Laupland KB, Zygun DA, Doig CJ, Bagshaw SM, Svenson LW, Fick GH. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med 2005; 31: 213219.
  • 30
    Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 2002; 8: 490495.